No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No. 59
1.United States Nuclear Regulatory Commission, “Loss of an Iridium-192 Source and Therapy Misadministration at Indiana Regional Cancer Center, Indiana, Pennsylvania on November 16, 1992,” Report NUREG-1480, Washington, D.C., 1993.
2.United States Nuclear Regulatory Commission, “Human Factors Evaluation of Remote Afterloading Brachytherapy,” J. R. Allan, R. T. Kelley, M. L. Quinn, J. W. Gwynne III, R. A. Moore, F. A. Muckler, J. Kasumovic, W. M. Saunders, R. P. Lepage, E. Chin, I. Schoenfield, and D. I. Serig, NUREG/CR-6125 (Vols. 1, 2, and 3), United States Nuclear Regulatory Commission, Washington, D.C., May, 1995.
3.G. P. Glasgow, J. D. Bourland, P. W. Grigsby, J. A. Meli, and K. A. Weaver, “Remote Afterloading Technology, Report No. 41 of the American Association of Physicists in Medicine Task Group No. 41” (American Institute of Physics, New York, 1993).
4.J. F. Williamson, G. A. Ezzell, A. O. Olch, and B. T. Thomadsen, “Quality Assurance for High Dose Rate Brachytherapy,” in Textbook on High Dose Rate Brachytherapy, edited by S. Nag (Futura, Armonk, NY, 1994), pp. 147–212.
5.G. J. Kutcher, L. Coia, M. Gillin, W. F. Hanson, S. Leibel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, Comprehensive QA for Radiation Oncology: AAPM Radiation Therapy Committee Task Group 40, AAPM Report No. 46, American Association of Physicists in Medicine (American Institute of Physics, New York, 1994).
6.R. Nath, L. L. Anderson, J. A. Meli, A. J. Olch, J. A. Stitt, and J. F. Williamson, “Code of practice for brachytherapy physics: AAPM Radiation Therapy Committee Task Group 56,” Med. Phys. 24, 1557–1598 (1997).
7.M. B. Podgorsak, L. A. DeWerd, and B. R. Paliwal, “The half-life of high dose rate Ir-192 source,” Med. Phys. 20, 1257–1259 (1993).
8.United States Nuclear Regulatory Commission, “Enforcement Actions: Significant Actions Resolved-Medical Licenses,” NUREG-094: Vol. 13, No. 3, Part 2; July–Sept., Washington, D.C., 1994.
9.United States Nuclear Regulatory Commission, “Quality Management in Remote Afterloading Brachytherapy,” United States Nuclear Regulatory Commission. NUREG/CR-6276, Washington, D.C., 1995.
10.United States Nuclear Regulatory Commission, “Quality Management Program and Misadministrations,” Federal Register 56 (143): 34104–34122, Thursday, 25 July 1991.
11.United States Nuclear Regulatory Commission, “Release of Patients after Brachytherapy Treatment with Remote Afterloading Devices,” NRC Bulletin 93-01 20 April 1993, U.S. Nuclear Regulatory Commission, Washington, D.C.
12.J. F. Williamson, L. L. Anderson, P. W. Grigsby, A. Martinez, R. Nath, D. Neblett, A. Olch, and K. Weaver, “American Endocurietherapy Society recommendations for specification of brachytherapy source strength,” Endocurietherapy/Hyperthermia Oncology 9, 1–7 (1993).
13.International Commission on Radiation Units and Measurement Report No. 38, “Dose and volume specification for reporting intracavitary therapy in gynecology,” Bethesda, MD, 1985.
14.L. L. Anderson, R. Nath, A. J. Olch, and J. Roy, “American Endocurietherapy recommendations for dose specification in brachytherapy,” Endocurietherapy/Hyperthermia Oncology 7, 1–12 (1991).
15.J. F. Williamson, “Simulation and source localization procedures for pulsed and high dose-rate brachytherapy,” in Quality Assurance: Activity Special Report No. 7 (Nucletron-Odelft International B. V., Veenendaal, The Netherlands, 1995), pp. 57–65.
16.B. R. Thomadsen, P. V. Houdek, R. van der Laarse, G. Edmundson, I. K. Kolkman-Duerloo, and A. G. Vissar, “Treatment planning and optimization,” in Textbook on High Dose Rate Brachytherapy, edited by S. Nag (Futura, Armonk, NY, 1994), pp. 79–145.
17.G. A. Ezzell and R. W. Luthmann, “Clinical implementation of dwell-time optimization techniques for single stepping-source remote afterloaders,” in Brachytherapy Physics, edited by J. F. Williamson, B. T. Thomadsen, and R. Nath (Medical Physics, Madison, 1995), pp. 617–640.
18.B. R. Thomadsen, S. Shahabi, J. A. Stitt, D. A. Buchler, F. J. Fowler, B. R. Paliwal, and T. J. Kinsella, “High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations,” Int. J. Radiat. Oncol., Biol., Phys. 24, 349–357 (1992).
19.B. R. Thomadsen, Chapter 32, “Clinical implication of remote afterloading, interstitial brachytherapy,” in Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadsen, and R. Nath (Medical Physics Publishing, Madison, 1995), pp. 647–677.
20.Radium dosage, the Manchester system, edited by W. J. Meredith (Livingstone, Edinburgh, 1967).
21.H. Kubo, “Verification of treatment plans by mathematical formulas for single catheter HDR brachytherapy,” Med. Dosimetry 17, 151–155 (1992).
22.H. Kubo and R. B. Chin, “Simple mathematical formulas for quick-checking of single-catheter high dose rate brachytherapy treatment plans,” Endocurietherapy/Hyperthermia Oncology 8, 165–169 (1992).
23.R. D. Rogus, M. J. Smith, and H. D. Kubo, “An equation to QA check the total treatment time for single-catheter HDR brachytherapy of known length and dose prescription depth,” Int. J. Radiat. Oncol., Biol., Phys.40, 245–248 (1998).
24.See, for example, J. F. Williamson, G. A. Ezzell, A. Olch, and B. R. Thomadsen, “Quality assurance for high dose rate brachytherapy,” in High dose rate brachytherapy: A textbook, edited by S. Nag (Futura, Armonk, NY, 1994), pp. 147–212.
25.G. A. Ezzell, “Quality assurance of treatment plans for optimized high dose rate brachytherapy,” Med. Phys. 21, 659–661 (1994).
26.G. P. Glasgow, “Radiation control, personnel training and emergency procedures for remote afterloading units,” Endocurietherapy/Hyperthermia Oncology 12, 67–79 (1996).
27.United States Nuclear Regulatory Commission Informational Notice 94-37: “Misadministration caused by a bent interstitial needle during brachytherapy procedure,” Office of Nuclear Materials Safety and Safeguards, Washington, D.C., 1994.
Data & Media loading...
Article metrics loading...
Full text loading...